| Period Ending | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|
|
Total Revenue
|
21,713,902
|
20,007,588
|
17,015,126
| | Cost of Revenue | 8,075,539 | 7,838,646 | 6,984,145 | | |
Gross Profit
|
13,638,363
|
12,168,942
|
10,030,981
| |
|
Operating Expenses |
|
Research Development | 2,559,612 | 2,149,787 | 1,888,015 |
|
Selling General and Administrative | 7,004,287 | 6,479,382 | 5,375,305 |
|
Non Recurring | 110,590 | 97,334 | 84,375 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
3,963,874
|
3,442,439
|
2,683,286
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (81,356) | (22,703) | 103,042 |
|
Earnings Before Interest And Taxes | 3,882,518 | 3,419,736 | 2,786,328 |
|
Interest Expense | 78,903 | 170,466 | 178,345 |
|
Income Before Tax | 3,803,615 | 3,249,270 | 2,607,983 |
|
Income Tax Expense | 917,598 | 640,385 | 638,297 |
|
Minority Interest | (153,404) | (147,548) | (69,691) |
|
|
|
Net Income From Continuing Ops | 2,732,613 | 2,461,337 | 1,899,995 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
2,732,613
|
2,461,337
|
1,899,995
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
2,732,613
|
2,461,337
|
1,899,995
|
|
0.09%